IIM
MDGL icon

Ironwood Investment Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Ironwood Investment Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-12,350
Closed -$752K – 163
2015
Q3 		$752K Buy
12,350
+43
+0.3% +$3.1K 0.28% 101
2015
Q2 		$961K Sell
12,307
-8,800
-42% -$738K 0.22% 98
2015
Q1 		$1.43M Buy
21,107
+8,037
+61% +$689K 0.27% 90
2014
Q4 		$1.21M Buy
13,070
+388
+3% +$40.1K 0.22% 96
2014
Q3 		$1.34M Buy
12,682
+4,045
+47% +$563K 0.24% 95
2014
Q2 		$1.24M Buy
8,637
+3,019
+54% +$441K 0.2% 99
2014
Q1 		$848K Buy
5,618
+3,458
+160% +$681K 0.12% 108
2013
Q4 		$396K Buy
2,160
+32
+2% +$5.86K 0.06% 136
2013
Q3 		$470K Buy
2,128
+26
+1% +$5.53K 0.07% 129
2013
Q2 		$367K Buy
+2,102
New +$548K 0.07% 133

Other funds holding MDGL

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ironwood Investment Management's MDGL Position: Q4 2015 in Review

Ironwood Investment Management sold out of Madrigal Pharmaceuticals (MDGL) in Q4 2015, closing a stake of 12,350 shares — an estimated $752K sold.

Ironwood Investment Management first reported a position in MDGL in Q2 2013 and held it in 10 quarters. The position peaked at $1.43M in Q1 2015. 75 funds tracked by Wall St. Rank hold MDGL as of Q4 2015.

  • Ironwood Investment Management reported no remaining Madrigal Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Ironwood Investment Management sold 12,350 Madrigal Pharmaceuticals shares in Q4 2015, an estimated $752K.
  • Ironwood Investment Management first reported a position in Madrigal Pharmaceuticals in Q2 2013 and held it in 10 quarters.
  • Ironwood Investment Management's Madrigal Pharmaceuticals position peaked at $1.43M in Q1 2015.
  • 75 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q4 2015.

Based on Ironwood Investment Management's 13F filing for Q4 2015, filed 21 Jan 2016.